Index - P/E 23.67 EPS (ttm) 4.09 Insider Own 24.42% Shs Outstand 885.01M Perf Week 2.26%
Market Cap 85.64B Forward P/E 15.97 EPS next Y 6.06 Insider Trans -16.21% Shs Float 668.87M Perf Month -4.05%
Income 3.68B PEG 0.91 EPS next Q 0.96 Inst Own 57.81% Short Float 1.16% Perf Quarter 16.11%
Sales 16.45B P/S 5.21 EPS this Y 39.27% Inst Trans 0.60% Short Ratio 2.10 Perf Half Y 75.21%
Book/sh 25.83 P/B 3.75 EPS next Y 27.23% ROA 1.26% Short Interest 7.74M Perf Year 84.36%
Cash/sh 12.99 P/C 7.45 EPS next 5Y 26.07% ROE 18.39% 52W Range 47.79 - 103.48 Perf YTD 16.80%
Dividend Est. 0.70 (0.73%) P/FCF 12.32 EPS past 5Y 14.69% ROI 5.19% 52W High -6.48% Beta 1.62
Dividend TTM 0.66 (0.68%) Quick Ratio - Sales past 5Y 121.30% Gross Margin 52.42% 52W Low 102.49% ATR (14) 2.84
Dividend Ex-Date Feb 15, 2024 Current Ratio - EPS Y/Y TTM 413.84% Oper. Margin 32.77% RSI (14) 49.11 Volatility 2.98% 2.86%
Employees 4490 Debt/Eq 2.17 Sales Y/Y TTM 210.96% Profit Margin 22.38% Recom 1.47 Target Price 116.74
Option/Short Yes / Yes LT Debt/Eq 2.10 EPS Q/Q 1114.91% Payout 15.88% Rel Volume 0.00 Prev Close 96.77
Sales Surprise 1.67% EPS Surprise 8.81% Sales Q/Q 124.53% Earnings May 01 BMO Avg Volume 3.69M Price 96.77
SMA20 -1.17% SMA50 -0.77% SMA200 27.47% Trades
Volume 0 Change 0.00%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-04-24 Initiated TD Cowen
Outperform
$96
Nov-30-23 Reiterated Oppenheimer
Outperform
$91 → $94
Oct-05-23 Initiated Wolfe Research
Outperform
$75
May-19-23 Initiated Citigroup
Buy
$69
Mar-02-23 Initiated Barclays
Overweight
$69
Nov-02-22 Upgrade BofA Securities
Neutral → Buy
$57 → $60
Oct-19-22 Initiated Credit Suisse
Neutral
$48
Dec-16-21 Initiated Wells Fargo
Overweight
$90
Dec-16-21 Initiated BofA Securities
Neutral
$86
Nov-19-21 Resumed Citigroup
Buy
$92
Oct-07-21 Resumed Jefferies
Buy
$74
Aug-11-21 Upgrade Deutsche Bank
Hold → Buy
$69 → $75
Aug-05-21 Upgrade JMP Securities
Mkt Perform → Mkt Outperform
$82
Jun-17-20 Initiated Piper Sandler
Overweight
$40
Feb-03-20 Upgrade Barclays
Equal Weight → Overweight
$37
Jan-13-20 Downgrade JMP Securities
Mkt Outperform → Mkt Perform
Oct-08-19 Initiated BMO Capital Markets
Outperform
Sep-23-19 Upgrade BofA/Merrill
Neutral → Buy
Sep-19-19 Reiterated Goldman
Buy
$34 → $35
Aug-05-19 Initiated Barclays
Equal Weight
$29
Show Previous Ratings
Today 08:00AM
07:32AM
Apr-24-24 02:44PM
02:31PM
01:17PM
01:10PM
Loading…
01:10PM
08:22AM
08:04AM
01:19AM
Apr-23-24 01:00AM
Apr-22-24 06:15PM
12:00AM
(The Wall Street Journal)
Apr-17-24 04:15PM
Apr-16-24 04:15PM
Apr-15-24 06:15PM
07:00AM
Loading…
Apr-12-24 07:00AM
Apr-11-24 12:14PM
11:36AM
06:57AM
05:04AM
Apr-10-24 04:45PM
02:03PM
10:03AM
07:00AM
Apr-09-24 06:15PM
Apr-04-24 09:02AM
Apr-03-24 07:01AM
Apr-02-24 07:00AM
Mar-26-24 07:49AM
03:08AM
12:09PM
Loading…
Mar-25-24 12:09PM
07:00AM
06:50AM
Mar-22-24 01:20PM
Mar-21-24 05:37PM
Mar-20-24 04:45PM
03:45PM
Mar-19-24 01:51PM
09:41AM
(The Wall Street Journal)
07:22AM
Mar-18-24 12:17AM
(The Wall Street Journal)
Mar-15-24 12:58AM
Mar-14-24 08:21PM
(The Wall Street Journal)
04:07PM
05:16AM
04:06AM
Mar-13-24 02:17PM
01:43PM
01:12PM
07:00AM
(The Wall Street Journal)
Mar-12-24 08:20PM
08:14PM
07:27PM
06:07AM
Mar-11-24 09:19PM
07:00AM
Mar-08-24 04:26PM
(Investor's Business Daily)
Mar-07-24 09:19PM
02:27PM
12:05AM
Mar-06-24 01:34PM
Mar-05-24 12:00PM
07:00AM
Mar-01-24 01:05AM
Feb-29-24 02:54AM
Feb-28-24 04:50AM
Feb-26-24 04:15PM
12:43PM
09:13AM
09:06AM
(The Wall Street Journal)
08:30AM
Feb-23-24 11:18AM
Feb-22-24 10:06AM
08:15AM
Feb-21-24 11:13AM
10:00AM
Feb-20-24 12:58PM
12:15PM
Feb-17-24 11:49AM
Feb-16-24 12:48PM
10:41AM
07:00AM
04:30AM
Feb-15-24 11:14AM
06:09AM
06:00AM
01:22AM
Feb-14-24 12:57PM
10:17AM
08:29AM
(The Wall Street Journal)
Feb-13-24 07:00AM
07:00AM
Feb-08-24 04:15PM
Feb-07-24 10:37AM
01:35AM
(Thomson Reuters StreetEvents)
Feb-06-24 01:53PM
(Morningstar Research) +5.80%
01:29PM
11:42AM
(The Wall Street Journal)
10:00AM
09:41AM
KKR & Co., Inc. operates as an investment firm. It offers alternative asset management as well as capital markets and insurance solutions. The firm's business segments include Asset Management and Insurance Business. The Asset Management segment engages in providing private equity, real assets, credit and liquid strategies, capital markets, and principal activities. The Insurance Business segment offers retirement, life insurance and reinsurance solutions to clients across individual and institutional markets. The company was founded by Henry Kravis, George R. Roberts, and Jerome Kholberg on May 1, 1976 and is headquartered in New York, NY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
KKR Group Partnership L.P. 10% Owner Apr 01 '24 Sale 10.74 6,000,000 64,440,000 0 Apr 03 06:21 PM KKR Alternative Assets LLC 10% Owner Mar 26 '24 Buy 25.00 571,429 14,285,714 1,000,687 Mar 28 04:33 PM KKR Alternative Assets LLC 10% Owner Mar 13 '24 Buy 24.94 286,402 7,142,857 429,259 Mar 15 04:15 PM KKR Group Partnership L.P. 10% Owner Mar 11 '24 Sale 9.87 13,800,000 136,206,000 0 Mar 11 05:32 PM KKR Group Partnership L.P. 10% Owner Mar 06 '24 Sale 54.46 19,866,397 1,081,923,981 583,493 Mar 08 04:30 PM KKR Group Partnership L.P. 10% Owner Nov 15 '23 Sale 10.90 3,000,000 32,700,000 0 Nov 17 04:19 PM KKR Group Partnership L.P. 10% Owner Aug 21 '23 Sale 36.85 15,000,000 552,750,000 4,570,327 Aug 23 04:53 PM KKR Group Partnership L.P. 10% Owner Aug 14 '23 Sale 37.00 10,000,000 370,000,000 19,644,896 Aug 16 04:31 PM KKR Phorm Investors L.P. 10% Owner Jul 21 '23 Buy 3.30 1,735,988 5,728,760 24,411,968 Jul 25 04:28 PM KKR Alternative Assets LLC 10% Owner Jun 30 '23 Buy 27.99 459,348 12,857,143 943,806 Jul 05 05:16 PM KKR Group Partnership L.P. 10% Owner Jun 01 '23 Sale 23.00 15,000,000 345,000,000 29,782,619 Jun 05 05:02 PM KKR Alternative Assets LLC 10% Owner May 30 '23 Buy 26.15 27,315 714,286 484,458 Jun 01 04:16 PM KKR Group Partnership L.P. 10% Owner May 17 '23 Sale 21.00 15,952,381 335,000,001 44,782,619 May 19 05:00 PM
Index - P/E 16.85 EPS (ttm) 5.83 Insider Own 3.03% Shs Outstand 99.95M Perf Week 2.35%
Market Cap 9.83B Forward P/E 13.64 EPS next Y 7.20 Insider Trans -2.11% Shs Float 96.97M Perf Month -4.30%
Income 611.00M PEG 2.60 EPS next Q 1.45 Inst Own 95.15% Short Float 3.93% Perf Quarter 23.36%
Sales 20.55B P/S 0.48 EPS this Y -10.50% Inst Trans 2.75% Short Ratio 3.24 Perf Half Y 79.77%
Book/sh 16.09 P/B 6.11 EPS next Y 15.29% ROA 2.20% Short Interest 3.81M Perf Year 42.41%
Cash/sh 12.28 P/C 8.00 EPS next 5Y 6.49% ROE 44.44% 52W Range 51.04 - 107.80 Perf YTD 30.03%
Dividend Est. - P/FCF 6.05 EPS past 5Y 40.40% ROI 3.49% 52W High -8.85% Beta 2.14
Dividend TTM - Quick Ratio 1.42 Sales past 5Y 2.48% Gross Margin 11.92% 52W Low 92.52% ATR (14) 2.95
Dividend Ex-Date Mar 13, 2000 Current Ratio 1.51 EPS Y/Y TTM 56.53% Oper. Margin 11.81% RSI (14) 49.88 Volatility 3.02% 2.68%
Employees 106500 Debt/Eq 10.08 Sales Y/Y TTM 7.17% Profit Margin 2.97% Recom 1.45 Target Price 113.56
Option/Short Yes / Yes LT Debt/Eq 9.88 EPS Q/Q 144.28% Payout 0.00% Rel Volume 0.00 Prev Close 98.26
Sales Surprise 2.03% EPS Surprise 67.31% Sales Q/Q 7.80% Earnings Apr 30 BMO Avg Volume 1.18M Price 98.26
SMA20 -1.70% SMA50 0.72% SMA200 26.22% Trades
Volume 0 Change 0.00%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-27-24 Upgrade Wolfe Research
Peer Perform → Outperform
$122
Mar-06-24 Initiated Barclays
Overweight
$113
Apr-21-23 Initiated Cantor Fitzgerald
Overweight
$73
Apr-19-23 Initiated JP Morgan
Overweight
$72
Jun-17-22 Initiated Loop Capital
Buy
$80
Mar-29-22 Initiated Wells Fargo
Overweight
$100
Feb-10-22 Upgrade UBS
Neutral → Buy
$83 → $111
Feb-09-22 Upgrade Truist
Hold → Buy
$90
Feb-09-22 Upgrade SVB Leerink
Mkt Perform → Outperform
$88 → $100
Jan-20-22 Upgrade Raymond James
Outperform → Strong Buy
$105 → $120
Jan-10-22 Resumed Citigroup
Buy
$91 → $96
Sep-27-21 Initiated SVB Leerink
Mkt Perform
$80
Sep-24-21 Initiated UBS
Neutral
$83
Aug-12-21 Upgrade Barclays
Equal Weight → Overweight
$62 → $77
Jul-23-21 Resumed Citigroup
Buy
$88
Jul-09-21 Initiated Seaport Global Securities
Buy
$80
May-03-21 Resumed Goldman
Buy
$89
Jan-08-21 Upgrade Jefferies
Hold → Buy
$60
Jan-05-21 Upgrade BofA Securities
Neutral → Buy
$50
Dec-15-20 Upgrade Deutsche Bank
Hold → Buy
$28 → $69
Show Previous Ratings
Apr-24-24 12:10PM
Apr-23-24 10:01AM
09:40AM
Apr-19-24 05:57PM
05:43PM
11:58PM
Loading…
Apr-17-24 11:58PM
Apr-05-24 06:15PM
Apr-03-24 12:45PM
09:30AM
Apr-02-24 12:58PM
Apr-01-24 06:45AM
Mar-28-24 08:00AM
Mar-22-24 06:15PM
Mar-15-24 01:49AM
Mar-13-24 06:15PM
11:54PM
Loading…
Mar-08-24 11:54PM
Mar-05-24 06:15PM
Mar-01-24 12:26PM
Feb-29-24 06:45AM
04:57AM
Feb-28-24 06:15PM
Feb-21-24 09:00AM
Feb-17-24 12:06AM
Feb-16-24 05:00PM
07:03AM
12:01AM
Feb-09-24 10:24AM
04:00AM
04:00AM
02:15AM
(Thomson Reuters StreetEvents)
07:24PM
Loading…
Feb-08-24 07:24PM
12:35PM
12:30PM
07:51AM
07:47AM
07:03AM
(Associated Press Finance)
06:57AM
06:30AM
Feb-06-24 10:34AM
Feb-05-24 09:16AM
Feb-02-24 09:12AM
Feb-01-24 08:03PM
(Morningstar Research) +7.70%
10:00AM
07:00AM
07:00AM
06:45AM
05:44AM
Jan-30-24 01:32PM
01:14PM
(The Wall Street Journal)
11:35AM
(The Wall Street Journal)
Jan-29-24 06:15PM
Jan-26-24 12:10PM
Jan-25-24 02:52AM
Jan-22-24 06:15PM
Jan-18-24 11:39AM
(The Wall Street Journal)
Jan-09-24 06:15PM
09:00AM
Dec-26-23 12:20PM
Dec-25-23 04:41AM
Dec-21-23 05:08AM
Dec-19-23 06:15PM
04:02AM
Dec-15-23 06:34PM
Dec-13-23 04:05PM
Nov-30-23 08:34AM
Nov-29-23 11:30AM
Nov-24-23 11:03PM
Nov-20-23 11:06AM
08:42AM
05:20AM
Nov-19-23 07:09PM
Nov-17-23 12:16PM
07:26AM
07:00AM
06:57AM
06:45AM
05:22AM
Nov-13-23 02:56PM
Nov-06-23 12:25PM
Oct-31-23 03:26PM
11:57AM
08:41AM
08:25AM
(Thomson Reuters StreetEvents)
06:49AM
01:15AM
Oct-30-23 08:30PM
06:16PM
06:00PM
05:50PM
04:47PM
(Associated Press Finance)
04:05PM
Oct-26-23 09:00AM
Oct-25-23 06:05PM
Oct-23-23 06:15PM
10:00AM
Oct-19-23 12:17PM
09:00AM
Oct-16-23 06:15PM
Oct-12-23 12:10PM
Oct-11-23 11:41AM
Tenet Healthcare Corp. engages in the provision of healthcare services. It operates through the Hospital Operations and Other, and Ambulatory Care segments. The Hospital Operations and Other segment is composed of acute care hospitals, ancillary outpatient facilities, urgent care centers, micro hospitals and physician practices. The Ambulatory Care segment includes the operations of the USPI joint venture and the company's nine Aspen facilities in the United Kingdom. The company was founded in 1969 and is headquartered in Dallas, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
MARK RICHARD J Director Mar 12 '24 Sale 98.98 14,000 1,385,720 33,303 Mar 14 08:00 PM Arbour Paola M EVP, Chief Information Officer Mar 06 '24 Sale 96.96 18,168 1,761,569 29,803 Mar 08 08:00 PM Arnst Thomas W EVP, Chief Admin. Officer & GC Mar 01 '24 Sale 94.84 17,000 1,612,234 8,148 Mar 05 08:00 PM Lynch Christopher S. Director Feb 15 '24 Sale 89.60 7,978 714,829 25,620 Feb 16 08:15 PM FISHER RICHARD W Director Feb 14 '24 Sale 88.21 2,100 185,241 20,127 Feb 15 08:00 PM FISHER RICHARD W Director Nov 22 '23 Sale 68.22 1,000 68,220 22,227 Nov 24 04:17 PM FISHER RICHARD W Director Nov 21 '23 Sale 66.33 5,000 331,650 23,227 Nov 24 04:17 PM Arbour Paola M EVP, Chief Information Officer Jun 02 '23 Option Exercise 31.46 38,556 1,212,952 54,357 Jun 06 04:46 PM Arbour Paola M EVP, Chief Information Officer Jun 02 '23 Sale 75.22 38,556 2,900,338 33,006 Jun 06 04:46 PM Arnst Thomas W EVP, Chief Admin. Officer & GC May 19 '23 Sale 73.12 21,178 1,548,602 0 May 23 05:01 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
